Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2022

Sep 21, 2022

29777_dirs_2022-09-21_7a31fe93-e67c-4ef6-9f98-ba5a472b688b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2022-09-15

Reporting Person: Babineaux-Fontenot Claire (N/A)